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Main points 
- Brain energy metabolism in organized hierarchically  
- Different organizational levels require different technical approaches 
- Technical strengths and weaknesses are made explicit  
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Abstract 
 
Neuroscience is a technology-driven discipline and brain energy metabolism is no exception. Once 
satisfied with mapping metabolic pathways at organ level, we are now looking to learn what it is 
exactly that metabolic enzymes and transporters do and when, where do they reside, how are 
they regulated, and how do they relate to the specific functions of neurons, glial cells, and their 
subcellular domains and organelles, in different areas of the brain. Moreover, we aim to quantify 
the fluxes of metabolites within and between cells. Energy metabolism is not just a necessity for 
proper cell function and viability but plays specific roles in higher brain functions such as memory 
processing and behavior, whose mechanisms need to be understood at all hierarchical levels, from 
isolated proteins to whole subjects, in both health and disease. To this aim the field takes 
advantage of diverse disciplines including anatomy, histology, physiology, biochemistry, 
bioenergetics, cellular biology, molecular biology, developmental biology, neurology and 
mathematical modeling. This article presents a well-referenced synopsis of the technical side of 
brain energy metabolism research. Detail and jargon are avoided whenever possible and emphasis 
is given to comparative strengths, limitations and weaknesses, information that is often not 
available in regular papers.  
 
 
  
   
“Each portion of matter may be conceived as like a garden full of 
plants and like a pond full of fishes. But each branch of every plant, 
each member of every animal, each drop of its liquid parts is also 
some such garden or pond.”  
      Gottfried W. Leibniz, Monadology 66-69, 1714 
 
Introduction 
Picture a student tantalized by one of our favorite questions: How is energy production coupled to 
energy demand? What are the roles of neurons and glial cells in this coupling? Information 
processing controls energy metabolism, but can it also work the other way round? Is epilepsy a 
metabolic disease? Is energy handling at the core of neurodegeneration? In search for guidance, 
she participates in the biennial International Conference on Brain Energy Metabolism 
(http://cecs.cl/icbem/). After listening to talks and reading posters she realizes that many different 
techniques are being applied to many experimental models. Each expert uses a different jargon: 
reversal potential, state 3 respiration, transacceleration, cataplerosis, glutamate enrichment, 
hyperpolarized, pixel shift, BOLD, default network, etc. One speaker shows single ion-channel 
recordings. The next one pyruvate carboxylation by mitochondria, and yet another links 
autofluorescence of mouse hippocampal slices to a genetic disease in humans. She leaves the 
meeting fascinated and bewildered. Would the channel behave similarly in situ? Is mitochondrial 
metabolism sensitive to cytoplasmic context? How does invertebrate metabolism relate to human 
metabolism?  
Our purpose here is to offer some technological guidance to our prospective colleagues (and to 
ourselves). Length restrictions preclude covering the ever-expanding technical range, so we 
apologize for possible omissions. Techniques are described and their strengths are stated briefly. 
Special attention is allocated to limitations, problems, and ever elusive underlying assumptions. 
We are not focusing here on the merits of experimental models, which are discussed in the article 
that introduces this special issue. Before going to the specifics, a theoretical framework may help 
to explain why such diverse approaches are required and why none of them may claim preference 
over the others.  
 
Energy metabolism is organized hierarchically 
Energy enters the brain as glucose, and leaves it minutes later in the degraded forms of water, CO2 
and heat. The incessant cascade of electrons is somehow harnessed to maintain the complex 
structure of the brain and to process information. The science of Brain Energy Metabolism aims to 
figure out how this is done. It is a relatively young branch of science, stemming from well-
established crafts that bring their own concepts, experimental models and techniques, 
assumptions and flaws:  anatomy, histology, physiology, biochemistry, bioenergetics, cellular 
biology, molecular biology, development, neurology, mathematical modeling, etc. This pleiotropy 
is necessary because energy metabolism spans multiple organizational levels, from nanometer-
scale interactions between intermediate metabolites and enzymes to organ-wide modulation of 
metabolism by hormones and behavior (Fig. 1). The existence of structural levels and discernible 
modules within levels is understood by thermodynamics as the expected result of binding forces 
becoming weaker as small structures accrete into larger ones but also has an evolutionary 
explanation, as building in modular fashion dramatically reduces error (Simon, 1962). The 
hierarchical organization of living structures such as the brain makes them amenable to dissection 
into smaller parts that remain functional. Much fundamental knowledge has been acquired from 
the study of isolated brain mitochondria, but which features are context-independent and which 
are not? To what extent does behavior in culture or in slices represent that observed in vivo? A 
given transporter was described and characterized in muscle cells, does it work the same way in 
astrocytes? To what extent is it safe to extrapolate from mouse to human? There are no a priori 
answers to these key questions but a rule of thumb may be applied:  the shorter the range of the 
phenomenon, the more likely it is to be unaffected by context. For example the 18 atoms of 
glutamate are joined by covalent bonds that withstand 198 
o
C. Because covalent bonds are much 
stronger than the forces that keep organelles, cells and tissues together, we know for sure that the 
glutamate powder on the shelf is structurally and functionally identical to the glutamate released 
in your visual cortex as you read these words. Thus, applying shelf glutamate to cells in culture is 
meaningful. Likewise, the ligand specificity of enzymes, transporters and channels is a robust 
property that may be characterized in a reduced context, i.e. in vitro. However, their regulation is 
most likely not.  
 
Pick your level, pick your technique 
The ideal technique would cover the whole organizational range, offering precise control of 
experimental variables while providing physiologically relevant data that may be reproduced by 
other laboratories. It should also be affordable and accessible. Of course, there is hardly such 
technique and trade-offs become necessary. The illustration in Figure 2 shows how some popular 
approaches distribute over the organizational space. The structure of purified enzymes and 
transporters is studied by means of X-ray diffraction, while understanding their function may 
demand complex systems like vesicles. Oxidative phosphorylation is studied by respirometry of 
isolated mitochondria, where substrates and cofactors are manipulated at will and fast 
phenomena are followed in real-time, or by respirometry of cell populations, where experimental 
control and temporal resolution are sacrificed for the benefit of subcellular context and 
physiological relevance. Cellular and organ level experiments could involve imaging of metabolites 
concentrations in brain cells in vitro and in vivo or optical control of signaling in cells of known 
phenotype. At the end of the spectrum are minimally invasive techniques like magnetic resonance 
spectroscopy (MRS), positron-emission tomography (PET) scanning and functional magnetic 
resonance imaging (fMRI), the only methods that may be used in human subjects.  
 
 
A      The stage: expression, location and interactions of enzymes and transporters 
Energy metabolism is distributed across the diverse cellular and subcellular compartments of brain 
tissue. Division of labor among compartments is evident from clear segregation of key enzyme 
activities, for example the almost exclusive astrocytic expression of glutamine synthase and 
pyruvate carboxylase (Martinez-Hernandez et al., 1977; Schousboe et al., 1977; Yu et al., 1983), 
which inform on the preferential role of these cells in glutamate recycling and anaplerosis. 
Differences between compartments have also emerged from the study of RNA transcripts in 
identified cell types acutely isolated from brain tissue by FACS (Cahoy et al., 2008; Zhang et al., 
2014). Recently, the possible introduction of expression artifacts by the sorting procedure was 
minimized by the ingenious expedient of co-culturing neurons and glial cells from different species 
followed by RNA sequencing and in-silico separation of the transcripts (Hasel et al., 2017). 
 
A.1 How to approach structure based on microscopy  
Microscopy has been the technique of choice for investigating the subcellular localization of the 
various enzymes, transporters and other proteins involved in brain metabolism. In order to make 
these targets visible under the microscope, different labeling techniques have been used. One 
group is based on the conversion by the target protein of a chemical substance that becomes a 
dye accumulating locally within the cell and that can be visualized by bright field microscopy (e.g. 
DAB staining of cytochrome oxidase(Hevner and Wong-Riley, 1989; Wong-Riley, 1989). The other 
major group makes use of antibodies that can specifically recognize the protein of interest 
(Martinez-Hernandez et al., 1977; Vannucci et al., 1997; Choeiri et al., 2002; Lehre et al., 1995; 
Chaudhry et al., 1995; Pierre et al., 2002; Bergersen et al., 2005; Pierre et al., 2009). After applying 
a primary antibody specific for the target protein, a secondary antibody directed against the 
primary antibody and carrying a tag is used to visualize its localization. The nature of the tag can 
vary and will determine the type of microscopy that will be subsequently used to reveal the 
presence of the target protein. The tag can be an enzyme which, in the presence of the 
appropriate substrate, will convert it into a dye that accumulates locally and can be visualized with 
bright field microscopy (e.g. peroxidase/DAB). If the tag is fluorescent (e.g. FITC or Cy3), then 
either widefield epifluorescence microscopy may be used, which is more suitable for analysis of 
tissue cultures and larger overviews, or single- and two-photon laser scanning microscopy, which 
can provide a 3D diffraction-limited view of tissues. If the tag is a heavy metal atom (silver or gold), 
then we can use electron microscopy, which increases the spatial resolution power compared to 
conventional brightfield or fluorescence microscopy. The fluorescent peptide or protein can then 
be visualized by fluorescence microscopy (Fig. 3A). Most reagents and antibodies are commercially 
available or can be obtained from the researcher who produced them. Two limitation of antibody 
detection, particularly for comparison purposes, are variable affinity and epitope-masking. As an 
alternative, the mRNA expression of a gene in a given cell type may be evaluated with genetic 
tools. The idea is to modify the gene of interest and place the sequence coding for a bright 
fluorescent protein of a particular color (e.g. eGFP, Venus, tdTomato) as a reporter to be 
expressed under the control of the promoter of the target protein. One example of this type of 
approach is the expression of tdTomato under the control of the promoter of the lactate 
transporter MCT1 gene introduced as bacterial artificial chromosome, which revealed preferential 
MCT1 expression in oligodendrocytes, a finding with consequences for glial-to-neuron lactate 
shuttling and the pathophysiology of white matter neurodegeneration (Lee et al., 2012).  
The main strengths of these various techniques and approaches are their capacity to distinguish 
the specific cell type within which a particular protein is found and then in which cellular 
compartment or subcellular domain the protein is localized. From this information, which may be 
obtained under normal, untreated conditions but also after stimulation or treatment, it is possible 
to glen information about the participation of a protein in a particular process. In the case of 
immunofluorescence combined with confocal microscopy, it is possible to determine whether two 
proteins colocalize, i.e. if they are located close to each other in the same subcellular 
compartment. The main limitations of these approaches are the specificity and availability of the 
visualizing reagents. It is essential to demonstrate the specificity of each antibody and sometimes 
good antibodies are unavailable. Resolution can also be an issue, depending of the degree of 
localization that is required. For the genetic techniques, discrepancies have been observed 
between the expression of the native protein and the reporter. Care should be taken to avoid 
over-expression of reporter proteins as this could cause abnormal expression patterns or toxic 
effects.  Although ideal for structural/localization purposes, these methods are rather limited for 
the study of dynamic processes. 
 
A.2 Protein-protein interactions, supramolecular complexes, and structural microdomains 
Fick’s law of diffusion states that the time required for a molecule to diffuse a specific distance 
increases as a function of distance squared. So, doubling the distance quadruples the time. Thus, 
protein-protein interactions can reduce the distance between active sites of enzymes and increase 
the rate of flux of substrates through multistep reactions. In fact, there is good evidence that 
formation of supramolecular complexes within mitochondria increases the rate of oxidative 
phosphorylation (Boekema and Braun, 2007) and that proton antennae in neighboring proteins 
increase the speed of the astrocytic lactate transporter (Stridh et al., 2012). Formation of 
complexes also likely improves the specificity of some reactions within nanodomains of a cell.  For 
example, interactions with a kinase or ubiquitin ligase might limit the number of proteins 
phosphorylated/ubiquitinylated upon activation.  
Astrocytes have fine processes that contact ~100,000 synapses (Bushong et al., 2002; see Fig. 3A) 
and endfeet processes that ensheath arterioles and capillaries (Iadecola and Nedergaard, 2007). 
Thus much like neurons, astrocytes are likely polarized cells in which proteins are selectively 
sorted into these functionally distinct domains and assembled into multiprotein complexes. A few 
studies have identified proteins that interact with the Na
+
/K
+
 ATPase or with glutamate 
transporters (Genda et al., 2011; Rose et al., 2009; Bauer et al., 2012). Since these proteins are 
enriched near synapses, this information may help us understand the functional properties of 
these nano-domains.  Similarly aquaporin-4 is enriched in endfeet and forms complexes with other 
proteins (Nagelhus and Ottersen, 2013). Essentially nothing is known about the mechanisms 
involved in this sorting and there is still a lot to learn about the complexes that are formed in these 
nano-domains and their functional significance. 
Many interactions are identified by a hypothesis-driven approach: two proteins are found to 
functionally interact and one tests for protein interactions (for examples, see Robinson and 
Jackson, 2016). In many cases, antibodies are used to immunoprecipitate a protein of interest and 
Western blots are used to determine whether an interacting protein is found in the 
immunoprecipitate (Isono and Schwechheimer, 2010; Kaboord and Perr, 2008). With discovery-
based strategies, novel interacting proteins can be identified, information which is used to 
generate and test hypotheses. Advancements in mass spectroscopy have made it relatively easy to 
identify proteins in immunoprecipitates. It is also possible to fuse a domain from a protein of 
interest to glutathione S-transferase (GST) with cloning strategies. The subsequent cDNA is then 
used to over-express the protein in bacteria, which is then purified and incubated with solubilized 
tissues of interest. Complexes are then isolated using glutathione-based affinity columns (Harper 
and Speicher, 2011). Variants of this strategy are used to test whether interactions between two 
proteins are direct and to map domains of proteins required for a given interaction. Finally one 
can use yeast two-hybrid based strategies to identify novel interacting proteins. Here, a domain 
from a protein of interest is fused to part of a transcription factor. Then, the hybrid is used to 
screen a library of target sequences fused to the rest of the transcription factor and interactions 
are identified as transcriptional activity (Ito et al., 2001). Candidates can be tested for co-
localization in tissues or cells of interest, for example by looking for covariance (Li et al., 2004). If 
one or both of the proteins are widely distributed, it is possible to determine whether the 
observed overlap occurs more frequently than that which would occur by chance, by using Monte-
Carlo simulation, e.g. (Genda et al., 2011). 
There are several issues with any of these approaches. First, it is at least theoretically possible that 
some interactions form after solubilization. This post-solubilization aggregation is likely due to 
either electrostatic or hydrophobic interactions and will increase linearly with protein abundance.   
Sequential rinses with buffers containing different concentrations of salt can reduce these 
physiologically irrelevant interactions. Second, antibodies used to immunoprecipitate a protein 
may directly bind to and precipitate non-specific targets. This can be partially addressed by 
performing ‘reverse immunoprecipitations’ with an antibody against the putative interacting 
protein. Third, the GST and yeast 2-hybrid approaches require guessing where potential 
interacting proteins might bind.  Fourth, there are several different types of detergents, including 
non-ionic, bile acid salts, ionic, etc. One needs to empirically identify the detergents that best 
solubilize the protein of interest and reduce non-specific binding of proteins in the lysate (for 
reviews, see Le Maire et al., 2000; Phizicky and Fields, 1995; Garavito and Ferguson-Miller, 2001; 
Seddon et al., 2004).   
It is ultimately important to rigorously demonstrate the relevance of an interaction in vivo. Super-
resolution microscopy has been improved to the point that the resolving power is in the 10 to 50 
nm range.  Although this resolution is not sufficient to demonstrate direct protein interactions, it 
can support the notion that two proteins exist in the same nanodomain. Mapping domains 
required for an interaction allow for generation of constructs or peptides that will function as 
dominant-negative inhibitors of the interaction. Of course, if multiple ‘interacting’ proteins are 
identified, we must guess which proteins form direct interactions; this is a daunting task because 
there may be many proteins in a supramolecular complex. For example, the post-synaptic density 
has about 2,000 proteins (Focking et al., 2016).  It is also possible to test for interactions by 
labeling two putatively interacting proteins with different fluorescent tags. One of the 
fluorophores is excited and energy is transferred to a second fluorophore by resonance. This 
technique is called intermolecular Förster resonance energy transfer (FRET) and only detects 
proteins that are within 10 nm of each other (Sekar and Periasamy, 2003; Jares-Erijman and Jovin, 
2003; Pietraszewska-Bogiel and Gadella, 2011). 
 
 
B            The players: function of enzymes and transporters. 
B.1 Enzyme activity  
Once the location and abundance of an enzyme have been established, the question of function is 
next to arise. To assess the specific activity of an enzyme time-dependent changes in the 
concentration of the substrate (or product) need to be determined, during the steady state, in 
tissue/cell homogenates under specified conditions (Lorsch, 2015), and at a wide range of 
substrate/ligand concentrations to obtain the main kinetic parameters: half-saturation or 
Michaelis constant (Km), half-inhibition constant (Ki), maximal velocity constant (Vmax) and turnover 
number (kcat; Purich, 1979; Purich, 1980; Purich, 1982; Brooks et al., 2004). This is essential when 
predicting metabolic fluxes controlled by enzymes according to substrate concentrations (Kaplan 
and Colowick, 1955; Herrero-Mendez et al., 2009), tissue damage (Adan et al., 2016) or drug 
discovery (Widder and Green, 1985; Zhang, 2017). 
The specific activity of enzymes is a very useful measurement, and is necessary for understanding 
the functional fraction. This is important for enzymes that, for instance, are highly susceptible to 
oxidation of key cysteine residues leading to inactivation, such as mitochondrial respiratory chain 
complexes (Bolanos et al., 1994; Bolanos et al., 1995). Subcellular fractionation followed by 
enzymatic analysis represents a good strategy for estimating specific activity within the natural 
environment (Murphy and Chan, 2014). The development of techniques for the use of in-gel 
activity assays for proteins in their native tertiary/quaternary structures, such as blue-native gel 
electrophoresis followed by NADH dehydrogenase activity for mitochondrial complex I (Murphy 
and Chan, 2014; Lopez-Fabuel et al., 2016) may also represent progress towards the 
characterization of enzyme activities in their natural conformation. 
The main drawbacks of enzymatic analyses are technical and of interpretation. Technically, the 
unfeasibility of detecting the substrate or the product forces that couple enzymatic reactions 
(Purich, 1982), although the product of which - usually NAD(P)H- can be easily determined. 
Whereas coupling often represents the only available approach for assessing the specific activity 
of an enzyme, it often generates parasitic reactions (Auld and Inglese, 2004) that mask, usually by 
overestimation, the actual enzyme activity. When the limitation is due to the low sensitivity of the 
method to detect the substrate/product, alternative approaches can be implemented to enhance 
sensitivity. Often, the use of fluorescent, luminescent and radiometric detection methods can 
overcome the sensitivity problems (Purich, 1980; Simeonov and Davis, 2004; Dahlin et al., 2004), 
although they require the use of more complex equipment and expensive probes. Kinetic 
parameters of enzymes responsible for post-translational changes in proteins are difficult to assess 
as they require more tedious analyses such as Western blotting followed by semi-quantitative 
estimation of the modified substrate (e.g., phosphorylation, ubiquitination, acetylation, etc; 
Glickman, 2004), hence complicating the accurate knowledge of the kinetic parameters of the 
enzyme. Another limitation of this technique is the absence of the physiological environment of 
the enzyme when its activity is determined. Kinetic parameters of enzymes are determined by 
adding cofactors and substrates to the reaction mixture at concentrations that might be far from 
the physiological concentrations in the cell, especially if saturating concentrations are used for 
determining Vmax. Furthermore, the specific cellular or subcellular localization of enzymes is not 
reflected in the reaction mixture, although efforts should be made to mimic the in-cell conditions 
(Dahlin et al., 2004). For enzymes that are naturally membrane-bound, the use of detergents may 
help solubilize the protein for easier access of substrates and cofactors, but very often the 
detergent interferes with light, fluorescent or luminescent detection methods (Simeonov and 
Davis, 2004). When the detergent cannot be used, due to interferences, the insolubilized 
membranes cause light scattering, which may preclude spectrophotometric analyses (Brooks et al., 
2004). Finally, the specific activity, which represents maximal activity, gives no information about 
the influence of other enzymes of the pathway on the metabolic flux (Almeida et al., 2004). A well 
know example is hexokinase, which under physiological conditions work at 10% of its maximal 
activity, as it is tonically inhibited by its product glucose-6-phosphate (Wilson, 2003). 
 
B.2  Activity of transporters and channels: tracers, fluorescence and electrophysiology 
The widespread availability of radioactive tracers at the dawn of the nuclear age led to detailed 
kinetic understanding of several membrane transporters, well before their molecular 
identification. For practical reasons, the best characterized transporters were (and still are) those 
expressed in erythrocytes, in particular the facilitative hexose transporter GLUT1 (LeFevre, 1948; 
Widdas, 1954), later found to dominate the glucose permeability of endothelial cells, astrocytes 
and oligodendrocytes. Radioactive indicator-dilution assays were developed for in vivo studies in 
animals that allowed the kinetic characterization of the transport mechanisms at the blood-brain 
barrier (Crone, 1965; Yudilevich and Sepulveda, 1976). In human, brain glucose transport 
parameters could be estimated by combining steady-state measurements of parenchymal glucose 
concentration obtained by MRS, microdialysis and microelectrodes, with mathematical modeling 
(Gruetter et al., 1998; Barros et al., 2007). Decades of radiotracer experiments in cultured cells and 
heterologous expression systems have shown that the selectivity and kinetic properties of 
transporters for energy metabolites such as glucose, lactate, pyruvate, glutamate and glutamine 
are insensitive to cellular context. What is less well understood is their regulation, that is, if and 
how the intrinsic activity and subcellular localization of the transporters responds to the large 
changes in metabolic demand that accompany neural activity. Excellent in terms of signal-to-noise 
ratio, radiotracer methods offer limited spatial and temporal resolution, which precludes the study 
of single cells, complex tissues or rapid regulatory phenomena. In the case of H
+
-coupled 
monocarboxylate transporters (MCTs), the carriers of lactate, pyruvate and ketone bodies, indirect 
single-cell characterization has been possible by means of intracellular pH electrodes or pH-
sensitive dyes like 2',7'-bis-(2-carboxyethyl)-5-(6)-carboxyfluorescein (BCECF; Single cell glucose 
transport determination is possible with the fluorescent glucose analogs 6- and 2-([N-(7-nitrobenz-
2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose; (6-NBDG and 2-NBDG; Speizer et al., 1985; 
Yoshioka et al., 1996). They are twice as big as glucose, and are therefore taken by GLUTs at a 
lower rate (Barros et al., 2009a), a property that can be taken advantage of to achieve real-time 
measurement of transport activity and thus detect fast regulatory changes (Loaiza et al., 2003; 
Porras et al., 2004; Porras et al., 2008). Detected by confocal microscopy in brain tissue slices or by 
two-photon microscopy in vivo, they have served to estimate the contribution of neurons and 
astrocytes to the uptake of sugar (Barros et al., 2009b; Jakoby et al., 2014; Chuquet et al., 2010). 
Presently, their performance has been surpassed by that of genetically-encoded fluorescent 
sensors (Section C.3), which provide a stronger signal and a direct readout of the metabolite of 
interest, avoiding the need for assumptions and controls about analog handling by transporters 
and enzymes.  
A substantial fraction of the brain´s ATP turnover is associated with the recovery of ion gradients 
dissipated by ion channels during synaptic activity (Harris et al., 2012). In addition, many 
metabolites possess a net charge and recent studies in glial cells have indicated that some of them 
may be transported by ion channels (Sotelo-Hitschfeld et al., 2015; Karagiannis et al., 2016). This 
makes electrophysiology an important tool not just for the manipulation but also for the 
understanding of brain energy metabolism. The electrical properties of brain cells are typically 
studied in acute tissue preparations and in cell cultures. In contrast to neurons, which are 
characterized by action potentials, glial cells have no swift electrical events taking place across 
their membranes. In addition, the plasma membranes of astrocytes and oligodendrocytes are 
extremely leaky due to high background activity of potassium channels. There are also no fast 
excitatory or inhibitory synapses on astrocytes or oligodendrocytes and therefore stimulation of 
an afferent pathway commonly used for activation of neurons cannot be used to synchronously 
“fire” them. For these reasons electrical recordings are less commonly used in studies of these 
cells. Recordings with extracellular electrodes can detect stimulus-evoked compound action 
potentials, CAPs (Stys et al., 1991), where changes in the extracellular ion distribution due to glial 
transporters do play a role, but it is very hard to separate the glial component from the 
contributions of other tissue elements. From the metabolic point of view, the in vitro recording of 
CAPs offers the advantage that the tissue can be maintained for extended periods in a perfusion 
chamber with temperature, degree of oxygenation and nutrient supply controlled by the 
experimenter. In a homogeneous tissue such as the optic nerve, the CAP represents the response 
of a common neural cell type, central white matter myelinated axons. However in less 
homogeneous tissue e.g. the hippocampus, the recorded response is from heterogeneous cell 
types is recorded, thus the response may not be a true reflection of the contribution of individual 
neural cell types (Cater et al., 2001; Brown et al., 2003). In vitro recordings of acutely isolated 
tissue may be problematic with regards to the diffusion barrier created by large pieces of tissue, 
where inadequate diffusion of oxygen and glucose may lead to anoxic and/or hypoglycemic 
conditions at the center of the tissue (Tekkok et al., 2005).  
Recordings with sharp glass electrodes are possible for large glial cells (Deitmer, 1992). 
Intracellular recordings in patch-clamp mode seem to be more suitable for studies of astrocytes, 
which are usually much easier to patch than neurons in spite of their small size. Using the patch 
clamp approach it is possible to perform an accurate pharmacological characterization of 
receptors expressed by astrocytes (Lalo et al., 2008; Palygin et al., 2011). However, such 
experiments work best when astrocytes are isolated because it is not always easy to localize the 
site of action of the drugs when applied to tissues. Experiments in vitro allow tight control of the 
perfusion media including concentration of metabolites and drugs and the recordings are much 
more stable. However, astrocytes are very sensitive to stress, which is inevitable during 
preparation of slices and they easily convert to a “reactive” phenotype that may have a somewhat 
different physiology to the naïve cells in situ. In addition, metabolic conditions in a slice never 
correctly mimic conditions in vivo. Most acute slice experiments are performed in solutions 
bubbled with 95% O2/5% CO2 mix, resulting in hyper-oxygenation of the superficial cells. For some 
experiments this is a problem, as shown for example in studies of neuro-vascular coupling where 
the O2 level was eventually reduced to 20% (Hall et al., 2012). However, using lower oxygen can 
easily lead to hypoxia in the center of a moderately thick slice (300 μm). In a similar vein, virtually 
all standard slice work is performed in solutions containing 10 mM glucose or more, while brain 
tissue glucose is about 1mM (Barros et al., 2017). This overloads superficial astrocytes with 
glucose. Finally, cultured astrocytes are ideally suited for patch recordings but culturing affects the 
morphology, physiology and metabolism of these cells, factors that can be ameliorated by co-
culturing with neurons (Mamczur et al., 2015; Hasel et al., 2017). In summary, patch clamp is 
perhaps the best electrophysiological approach for studying astrocytes, but caution is required 
when extrapolating from data obtained on isolated astrocytes. It should also be remembered that 
while recording with patch electrodes, we artificially impose on the cell our ideas about the 
intracellular concentration of ions and metabolites because pipette solutions rather quickly dialyse 
into the astrocyte. Thus, our conclusions about the currents in these cells are only as accurate as 
our knowledge of their native intracellular ion composition. 
 
B.3 Optogenetic actuators: manipulating metabolism 
Optical control of electrical and signaling events in brain tissue in situ is in principle highly 
attractive because it seems to be non-invasive, fast and can be targeted to individual cells and 
cellular populations. Although light-sensitive proteins that affect cellular functions in plants have 
been known of for a long time, a major shift in neuroscience took place around 2003-2006 when it 
was demonstrated that such proteins can be expressed in mammalian neurons and used to 
activate them (Nagel et al., 2003; Boyden et al., 2005; Bi et al., 2006). Channelrhodopsin-2 (ChR2), 
which was (and still is) the most popular member of this family behaves as a light-gated channel 
permeable to sodium, potassium, protons and Ca
2+
. Manipulating sodium conductance presents 
an obvious way to depolarize neurons and trigger action potentials on demand. This is by far the 
most common use for this protein, which can be targeted to specific populations of cells using 
molecular and genetic approaches, and it will be very interesting to exploit it to investigate the 
role of specific neurons on local energy metabolism. ChR2 has also been used to activate 
astrocytes (Fig. 3F; Gourine et al., 2010), where it triggered Ca
2+
 elevations, though this required 
an application of several seconds of pulsing blue light (NB: constant blue light is a notorious source 
of artifacts). The Ca
2+
 increases were largely dependent on thapsigargin-sensitive internal Ca
2+
 
stores (Figueiredo et al., 2014; Perea et al., 2014). ATP release was also documented from ChR2-
stimulated astrocytes (Gourine et al., 2010). Many studies in the meantime have used ChR2 to 
activate astrocytes, though it should be noted that this is not an ideal tool for controlling these 
cells. A significant Na
+
 influx most likely affects multiple Na
+
-dependent transporters on astrocytes 
and the downstream effects become hard to disentangle. Prolonged ChR2-mediated activation 
leads to acidification of astrocytes due to a build-up of lactate (Tang et al., 2014). Since ChR2 does 
not mimic any obvious endogenous physiological mechanism operating in astrocytes, it is 
reasonable to explore alternatives. Attempts to use exotic approaches such as the light sensitive 
proton pump Arch have also been made (Poskanzer and Yuste, 2016; Beppu et al., 2014), but the 
actions of this protein on astrocytes are even less clear than those of ChR2. Light-activated G-
protein coupled receptors (GPCR) have been used (Tang et al., 2014) with the assumption that via 
this route events can be evoked that are similar to the native signaling in the brain where 
astrocytes are mainly controlled via GPCRs. These constructs however need to be used with 
caution because, when expressed at high level, GPCRs have a tendency to signal without any 
external trigger. Thus, overexpression, commonly used in many experiments, can be seen as a 
problem. An interesting new approach is to use a dimerization strategy for optical activation of 
signaling, for example activities of kinases. For astrocyte research a construct has been introduced 
that triggers Ca
2+
 entry via the ubiquitous CRAC channels (Kyung et al., 2015). Even though this 
tool may not be fast enough for triggering really rapid events, it seems that for many cases it can 
be advantageous, because at least it is a clearly defined mechanism for increasing astrocytic Ca
2+
. 
To summarize, the use of optogenetics for the study of brain energy metabolism is just starting, 
with a promising future of ever more specific and powerful ways to manipulate individual cells.  
 
 
C.           The play: metabolite concentrations and fluxes 
  
C.1 Respirometry 
Neural activity is tightly coupled to local fuel oxidation. The oxygen consumption rate (OCR) is 
therefore highly valuable information when characterizing cellular bioenergetics or diagnosing 
diseases. After decades of productive use for research and teaching, the estimation of oxygen 
consumption with manometry (Warburg, 1928) was superseded by easier and more accurate, real-
time determinations by using polarography (Clark et al., 1953). Whilst the traditional Clark-type 
electrode has delivered most of our current knowledge of mitochondrial bioenergetics, it has 
disadvantages (Zhang et al., 2012). Oxygen often leaks from the chamber through junctions and 
holes used for the administration of drugs and inhibitors; assembly of the equipment is tedious, 
time consuming and requires frequent calibration; the electrode is easily oxidized or damaged, 
and thus has a short lifespan; the need for continuous stirring to mix the cell or mitochondrial 
suspension usually harms the sample, in particular when analyzing isolated intact mitochondria; 
and since several of the inhibitors used to characterize the contribution of mitochondrial 
complexes to oxygen consumption are lipid soluble, the chamber needs to be thoroughly washed 
between samples. Whilst the chamber size is often fixed, the internal volume can be adjusted 
between 0.3-2 ml. However, the best results are often obtained with large sample volumes 
(usually, 1 ml), thus requiring large amounts of biological material for the analysis. This makes the 
system unsuitable for screenings. The appearance of multiwell plate respirometers has fired up 
the field (e.g. Agilent technologies/Seahorse Bioscience, Presens). These devices are built to 
simultaneously determine OCR and extracellular acidification rate (ECAR) in 24- or 96-well plates 
of adherent rather than suspended cells. OCR is determined using an oxygen-sensing fluorophore 
instead of the traditional oxygen-consuming electrode, and ECAR, with a pH sensor. Though 
popular, the high cost of both the instrument and the single-use plates are a disadvantage. In 
addition, ECAR is often thought to reflect glycolysis rate because the release of lactate acidifies the 
extracellular medium. However, caution should be taken because the CO2 released by the 
tricarboxylic acid activity significantly contributes to extracellular acidification (Mookerjee et al., 
2015; Mookerjee et al., 2017). The Clark electrode and the fluorophore-based multi-well 
instruments are highly valuable tools for characterizing aerobic metabolism in biological samples. 
Choosing one or the other depends on sample type and on flexibility in the study design. For 
instance, the Clark-type electrode chambers are very useful when the sample size is not limiting, 
as it provides more accuracy and time resolution, but the method is time consuming, such that 
only a few samples can be assayed in a day. This approach is also suitable for tissue slices or 
isolated mitochondria in suspension, as well as intact or permeabilized cells in suspension. It 
should be noted that harvest of neurons from a culture dish for assay in suspension leaves behind 
the neuronal processes and the mitochondria within them.  With both assay platforms, a large 
number of substrates, inhibitors or uncouplers can be used to better characterize the 
bioenergetics of the sample. Selective permeabilization of the plasma membrane allows control of 
substrate delivery to the mitochondria, and avoids the need for isolation of mitochondria from 
cultured cells (Divakaruni et al., 2014). The multi-well apparatus, in contrast, is very useful for 
accurate screenings in intact adherent cells, permeabilized adherent cells, or isolated 
mitochondria and requires a smaller sample size (around 1-3 x 104 cells/well or 1-3 micrograms of 
isolated mitochondria/well; Divakaruni et al., 2017; Rogers et al., 2011). This is particularly 
important when determining OCR in highly differentiated cells, such as neurons, given the low 
yield in these preparations. Note that multi-well respirometry is routinely employed in the 
absence of bicarbonate, a substrate of the anaplerotic enzyme pyruvate carboxylase and a 
regulator of astrocytic glycolysis (Ruminot et al., 2011). Multiwell respirometry is also constrained 
in terms of temporal resolution, with a typical rates integrated over 2-5 minutes. One limitation 
common to both oxygen electrodes and multi-well methods is the need for homogenous cell 
populations, which is not ideal for the study of brain cells, as neurons and astrocytes foster their 
mutual functional and metabolic differentiation (Barres et al., 1990; Mamczur et al., 2015; Hasel et 
al., 2017). A limitation of the use of isolated brain mitochondria in either apparatus is the fact that 
the mitochondria arise from multiple different cells types, thus specific information on the 
function of neuronal versus astrocytic mitochondria is lost in this approach.  However, 
respirometry can be performed on preparations of synaptoneurosomes, which are resealed 
synaptic vesicles created upon homogenization of brain tissue that contain mitochondria from 
synaptic terminals (Choi et al., 2009). 
 
C.2 Extracellular microdialysis and enzyme-based probes  
Given that the interstitial fluid is the medium of exchange between blood, the cerebrospinal fluid 
and the intracellular compartments of neuron and glia (Ransom, 2009), the ability to measure 
interstitial metabolites is crucial. However, the space left between brain cells is only 20 nm wide, 
which makes probing its composition a major technical challenge. Dialysis probes have been used 
to measure metabolic substrates from awake, moving animals (Brown et al., 2011). Placement of 
the dialysis probe requires complex surgery from which the animal recovers. The probes can be 
permanently attached to the animals’ skull with the sensing component extending into the brain 
parenchyma. The probe is guided through the brain parenchyma until a desired location is 
reached, which creates considerable localized damage and forms a 3
rd
 space that fills with the 
contents of damaged cells, and whose composition clearly does not represent the baseline 
interstitial fluid. However this perturbation dissipates over time as local repair mechanisms tend 
to normalize the 3
rd
 space contents. The interstitial fluid is sampled by applying backpressure, such 
that a small volume is drawn up into the probe (5-10 µl) to be later analyzed by HPLC. Repeated 
samples can be withdrawn over extended periods of time (days to weeks) thereby facilitating 
longitudinal studies. Advantages of this technique include its use for extended periods and the 
accuracy of HPLC analysis. Some disadvantages are that it does not provide real-time information, 
it disrupts the tissue, has low spatial resolution. It is a hotly debated area whether the samples 
reflect the real environment in the interstitial space. 
Real-time measurements of brain interstitial fluid can be obtained with enzyme-based 
microelectrodes. Probes can be as fine as 7 µm in diameter with the active tip between 100 and 
500 µm in length. The greater the surface area of the tip the greater the temporal resolution. Such 
probes are useful for recording from homogeneous brain structures such as isolated optic nerve 
(Yang et al., 2014b) and hippocampus (Fig. 3E; Newman et al., 2011; Frenguelli et al., 2003). 
However, as the probe records the aggregate signal from the entire tip area, care should be taken 
in interpreting data acquired from brain areas with heterogeneous cell populations. Those probes 
currently available can sense a multitude of compounds of interest to metabolic studies, including 
ATP, adenosine, acetylcholine, glucose, lactate, D-serine, choline, glutamate. The sensors can be 
calibrated prior to the experiment and are thus able to provide real-time estimates of 
concentrations, and they can be used for both in vivo and in vitro studies. A great advantage of 
modern commercially available sensors is that several probes may be used simultaneously to 
measure the concentrations of multiple metabolically relevant compounds e.g. glucose and 
lactate, ATP and adenosine (Fig. 3E; Frenguelli et al., 2007; Newman et al., 2011). Microsensors 
can be used in parallel with other real-time techniques, e.g. electrophysiology (Brown et al., 2012; 
Yang et al., 2014b) and genetically-encoded intracellular nanosensors (Machler et al., 2016). The 
power of combining functional assays with the real-time measurement of metabolic substrates 
has proven to be very effective in determining key processes in both grey and white matter. 
 
C.3 Genetically-encoded fluorescent nanosensors for metabolites 
Metabolite nanosensors are chimeric proteins that change their optical properties upon binding a 
ligand (Tsien, 2009; Fehr et al., 2003). Their specificity is conferred by a recognition domain, such 
as a bacterial periplasmic protein or a transcription factor, and their fluorescence by one or two 
fluorescent proteins, such as GFP, mTFP or Venus. Many of them are based on intramolecular 
FRET. Expressed in cellular compartments, the nanosensors are detected by microscopy: wide 
field, confocal or two-photon. In brain cells, measurements have been reported for glucose, 
glutamate, ATP, ATP/ADP, NADH/NAD
+
, lactate and pyruvate, reviewed in San Martín et al., 2014b. 
Most sensors are easily available through the non-profit repository Addgene. The main strength of 
these tools is resolution, which for high-end microscope setups is in the order of seconds and 
micrometers. Thus, they provide a real-time estimation in single cells. Being genetically-encoded, 
they can be targeted to organelles and subcellular domains  (Pendin et al., 2017). Their most 
common and robust use is to report metabolite fluctuations in before-and-after experiments, for 
example when characterizing the effect of a physiological or pharmacological perturbation (e.g. 
see Fig. 3G). Using standard transfection or viral expression systems, sensor concentration is about 
10 µM (Miyawaki et al., 1999), which is lower than the physiological concentration of most 
metabolites and therefore metabolite sequestration and slow dissociation kinetics are not usual 
concerns. An important exception is NADH, which is in the nanomolar range.  
As they are proteins, nanosensors are potentially susceptible to their physical environment. Some 
of the early versions were sensitive to pH, which could be corrected by parallel pH measurements. 
Their main weakness is that they are difficult to calibrate. One important caveat, which is not 
always explicit, is that it is not safe to draw conclusions from differences in intensity between cells. 
Even for FRET-based and other ratiometric sensors, the readout is affected to some extent by 
expression level due to non-linearities in the optical path. To compare cells, a calibration is 
therefore required. The simplest one-point calibration is achieved by forcing a reading at one end 
of the binding curve (i.e. zero or saturation) and then using the affinity constant and maximum 
fluorescence change determined in vitro to extract concentrations by interpolation (Barros et al., 
2014). If both ends of the saturation curve are accessible, a more robust two-point calibration 
protocol becomes feasible, where only affinity needs to be assumed as shown for the pyruvate 
sensor (San Martín et al., 2014a). Avoiding assumptions by recurring to a full in situ calibration is 
possible (Bittner et al., 2010) but is seldom practical, as it demands harsh permeabilization and/or 
metabolic inhibition procedures that may perturb the sensor itself. When quantitative data are 
available, nanosensors may be used to measure absolute flux by means of inhibitor-stop protocols 
(Bittner et al., 2010; San Martín et al., 2013; San Martín et al., 2014a). As both calibration and 
quick transporter inhibition are needed, this kind of assay is currently restricted to cells in culture 
and in slices. Inhibitor-stop methods assume that there is no quick adaptation to the inhibition, 
which has to be evaluated on a case-to-case basis.  
Nanosensing is an emerging technology and probes for other metabolites are surely on their way. 
One example is a sensor for NADP
+
 (Cameron et al., 2016), which may help in tackling the cryptic 
pentose phosphate pathway (Bouzier-Sore and Bolanos, 2015). In parallel, existing sensors are 
being improved and extended in terms of brightness, affinity, dynamic range and spectra (e.g. red-
shifted for deeper tissue penetration by reducing scattering). One important objective at hand is 
the generation of extracellular sensors to approach the brain interstice in non-invasive manner. 
 
C.4 In vivo optical imaging: from autofluorescence to genetically-encoded sensors and transgenic 
animals 
Brain energy metabolism has been the focus of studies since optical imaging methods began in the 
1960s (Chance et al., 1962), where changes in tissue UV autofluorescence observed upon altering 
respiration in vivo were interpreted as changes in the NAD
+
/NADH ratio (Mayevsky and Chance, 
1975). This and its relative flavoprotein autofluorescence imaging have been widely applied 
(Shibuki et al., 2003; Weber et al., 2004; Shuttleworth, 2010; Reinert et al., 2011; Kasischke et al., 
2004). In the early reports, the dynamics of hemoglobin oxygenation was discussed, a 
phenomenon that was later exploited by Grinvald and colleagues to map brain activity (Malonek 
and Grinvald, 1996), and which paved the way for the development of blood oxygenation level 
dependent (BOLD) fMRI  (Ogawa et al., 1990). Oxy- and deoxyhemoglobin can be discerned 
optically due to their differential absorption spectrum. However, the intrinsic optical contrast 
mechanisms have only marginally helped to generate mechanistic insight into cell-specific 
metabolic processes, because the signals are difficult to discriminate from each other, and hard to 
quantify and interpret (see Box 1). After their successful use in cultured cells and brain tissue slices 
(Section B.4), fluorescently labeled substrates were used to investigate energy metabolism in 
combination with two-photon microscopy (Denk et al., 1990; Zipfel et al., 2003). Using the non-
metabolized fluorescent glucose analog 6-NBDG, an acute increase in glucose uptake was detected 
in astrocytes but not in neurons of the somatosensory cortex of stimulated rats (Chuquet et al., 
2010). However, the optical properties of NBDGs are not favorable because of a very low two-
photon cross-section. Alternative fluorescent glucose analogues were developed (Kovar et al., 
2009; Tian et al., 2009) and used in vivo (Lundgaard et al., 2015), but the data remain difficult to 
interpret because some are hardly transported due to high molecular weights of 1.3 kDa (Kovar et 
al., 2009; Lundgaard et al., 2015). The advent of genetically encoded sensors for energy substrates 
(Section C.3) promises to be a significant advance for the field of brain energy metabolism, as they 
offer cellular resolution and real-time measurements (Fig. 3G; Lerchundi et al., 2015; Sotelo-
Hitschfeld et al., 2012; Machler et al., 2016). In combination with advanced viral expression 
vectors and hopefully transgenic mice (see below), these sensors are particularly well suited for in 
vivo research using two-photon microscopy. Quantitative measurements of partial pressure of 
oxygen (pO2) in vivo can be obtained with phosphorescence lifetime imaging microscopy (PLIM), in 
which a phosphorescent dye produces a decaying light signal after a short illumination. This decay 
is shortened by the presence of oxygen and its half-life can be translated to pO2 in absolute units. 
New phosphorescence probes were recently developed that can be two-photon excited (Esipova 
et al., 2016; Esipova and Vinogradov, 2014), which greatly widens the range of in vivo applications 
(Lecoq et al., 2011; Lyons et al., 2016; Parpaleix et al., 2013; Sakadzic et al., 2010; Sakadzic et al., 
2011). Until recently, high resolution imaging was only possible in anesthetized animals. A general 
concern for in vivo optical imaging and in vivo experimentation are the effects of anesthesia on 
metabolic processes. For this reason, an increasing number of laboratories are now using head-
restrained awake rodents even with two-photon microscopy at single cell resolution. 
Transgenic animals for metabolic imaging. The study of brain structure and function has been 
significantly facilitated by the availability of transgenic reporter animals, from nematodes to 
mammals, contributing for example, to the discoveries of the neurogenic potential of embryonic 
glia (Malatesta et al., 2003) and microglial motility (Nimmerjahn et al., 2005). More recently, 
genetically encoded sensors have been used as biosensors to visualize transmitter- and behavior-
evoked Ca
2+
 signals (Akerboom et al., 2012; Paukert et al., 2014). In transgenic animals the sensors 
are expressed permanently at constant levels over generations, a distinct advantage over viral 
transduction, which requires injection of each animal, with the possibility of tissue injury and 
inflammation. In addition, transgenesis provides a higher degree of flexibility regarding cell-
specific expression and size of the reporter construct. The generation of transgenic mammals is 
however time consuming, labor intensive and expensive. Another important drawback is the 
scarcity of appropriate promoters to reach sufficient expression levels in specific cell types, but 
strategies have been developed to address these limitations (Hirrlinger et al., 2009; Madisen et al., 
2015). To our knowledge there are only two transgenic mouse models to measure metabolites in 
brain tissue at this time: one that ubiquitously expresses a nanosensor for pyruvate (Bulusu et al., 
2017) and the other specific for neuronal ATP (Fig. 3G; Trevisiol et al., 2017). The pyruvate sensor 
was used to reveal the spatiotemporal dynamics of tissue explant glycolytic activity during 
development and the ATP sensor allowed imaging, for the first time, of the frequency-dependent 
energy demand of optic nerve axons.  
The age of metabolism studies using transgenic animals is just beginning. Novel genetic tools such 
as CRISPR/Cas9 (Cong et al., 2013; Wang et al., 2013) facilitate particularly the generation of 
mouse lines with loxP-flanked transcriptional "stop" sequences followed by nanosensors targeted 
to a single well-defined gene locus (e.g. at ROSA26). Combinatorial breeding of mice with 
expression of inducible and cell-specific Cre-DNA recombinase and ROSA-nanosensor mice will 
provide promising opportunities to explore the many facets of energy metabolism in the 
mammalian brain. Transgenic C. elegans and D. melanogaster lines have been generated that 
express an ATP sensor (Tsuyama et al., 2013). Recently, fruit fly lines selectively expressing 
pyruvate and glucose sensors in mushroom body neurons helped to show that energy metabolism 
can play an instructional role in long-term memory encoding (Plaçais et al., 2017), a role that 
appears to extend to behavior (Li-Byarlay et al., 2014). Another fruit fly study expressed a glucose 
sensor to characterize the delivery of glucose to brain cells (Volkenhoff et al., 2017). Short life 
cycle, relatively inexpensive experimentation and the availability of powerful tools for genetic 
manipulation, renders worms and flies very attractive for comparative studies of brain energy 
metabolism using imaging probes.   
 
C.5 2-deoxy-[
14
C]glucose and [
18
F]fluorodeoxyglucose methods for the measurement of local 
glucose utilization  
2-Deoxy-D-glucose (2DG) is an analogue of glucose (a hydrogen atom replaces the hydroxyl group 
on the second carbon) and this single structural difference is responsible for the chemical 
properties that make 2DG so suitable for the measurement of the rates of glucose utilization in the 
brain in vivo. 2DG is transported in the cell and metabolized qualitatively like glucose but only 
through the first step of the glycolytic pathway to provide 2DG-6-phosphate (2DG-6P). Since 2DG-
6P is not metabolized further to a significant extent, its rate of accumulation is proportional to the 
amount of glucose used by the cell. Using an appropriate mathematical model of enzyme kinetics 
and [
14
C]-labeled 2DG associated with autoradiography (a technique using X-ray films to visualize 
radioactive molecules with a spatial resolution of approx. 50 µm), the [
14
C]-2DG method provides 
quantitative metabolic maps (in µmol of glucose/g/min) of the brain in which regions of altered 
activity can be easily visualized (Sokoloff et al., 1977). This method can be used in different 
species, yields massive amounts of data and has provided unequivocal evidence that energy 
metabolism is linked to local functional activity. This method was adapted for use in humans with 
[
18
F]fluorodeoxyglucose (FDG) and a positron emission tomography (PET) scanner (Reivich et al., 
1979), which remains useful as a tool for mechanistic investigation of brain energy metabolism in 
animals (Zimmer et al., 2017).  
Absolute quantification of glucose utilization is possible thanks to the use of 
14
C-2DG, but many 
laboratories lack authorization to work with long life radioactive isotopes. The operational 
equation based on the original model requires plasma glucose (glucose oxidase method) and [
14
C]-
2DG concentrations (liquid scintillation counter) to be sampled frequently during a 45-min period, 
for which intravenous and intra-arterial catheters are inserted. While this is feasible in large 
animals, this can represent a technical limitation in mice, the choice animal model in the 
neurosciences. Also, the method requires that the brain of the animal is processed for 
autoradiography soon after completion of the experiment. Therefore only one measurement is 
possible per animal. The brain is cut entirely into 20 µm-thick sections with a cryostat and dried 
sections mounted on coverslips are left in contact with an X-ray film or phosphor screens. After 
exposure data can be read out with means of a specific image analysis system or phosphor-imager. 
The method cannot measure individual cells so that it is not possible to separate, for example, the 
contribution of neurons and glial cells. 2DG and to a larger extent FDG (high electronegativity of 
the fluorine-18 atom) do not have the same affinity as glucose for either glucose transporters or 
hexokinase. For quantitative analyses, these differences must be corrected for by the lumped 
constant, a parameter present in the operational equation used to determine the local rate of 
cerebral glucose utilization. While the operational equation has been thoroughly validated for its 
use in physiological conditions, it may not apply in specific pathophysiological conditions in which 
cardiovascular function or blood glucose levels are altered. FDG remains the most frequently used 
tracer in PET imaging, particularly for the detection and staging of tumors, in spite of the low 
spatial resolution of PET, the relative invasiveness of the method and the radiation dose due to the 
injection of [
18
F]-FDG. The use of fMRI-BOLD (see Box 1) now represents the gold standard to study 
the human brain at rest and during increased functional activity. 
Even if the 2DG/FDG method cannot provide information on the fate of glucose downstream of 
the first hexokinase step, it is as yet the only one that provides quantitative measurement of local 
glucose consumption in various structures of the brain. The recent development of computerized 
procedures for the automatic acquisition and 3D reconstruction of postmortem autoradiographic 
volume images now permits voxel-wise statistical methods to 3D-analyze the differences in 
glucose use in different groups of animals (without a priori identification of Region-of-Interest), as 
is done in humans (Fig. 3B; Dubois et al., 2010; Boussicault et al., 2014). 
 
C.6 Magnetic Resonance Spectroscopy 
Combined with MRI, MRS is a powerful technique that permits simultaneous visualization and 
quantification of dozens of metabolites contained in the brain area studied. The major advantage 
of MRS though is the possibility to obtain metabolic information in a non-invasive manner.  
Nuclear magnetic resonance arises from the interaction between atomic nuclei that possess an 
intrinsic angular momentum, or spin, and a magnetic field. This interaction is a very weak one that 
confers a low sensitivity on this technique, depending on the nucleus considered, the signal being 
stronger for 
1
H and much weaker for 
13
C, for example. Most of the in vivo studies are thus 
1
H-MRS. 
Metabolites are analyzed in a voxel, or volume of interest, located on the MR image acquired just 
before MRS (Fig. 3C). Accuracy is therefore strongly dependent on the immobility of the animal, 
which can be controlled by performing another MRI just after MRS. Anesthetic choice is also very 
important, especially for metabolic studies, since many drugs have an impact either on the 
vascular response or on metabolite contents (Horn and Klein, 2010; Tchaoussoff et al., 1991). Note 
that only metabolites present at a concentration higher than 1mM may be detected by MRS. 
Moreover, spatial and temporal resolutions are rather low, for voxels are in the mm
3
 range, thus 
preventing discrimination at the cellular level, and, to get enough signal-to-noise ratio, 
acquisitions are performed over minutes rather than seconds. This temporal resolution is even 
lower with 
13
C-MRS, which has a detection level 4 orders of magnitude lower than that of 
1
H. 
Therefore, the use of 
13
C-labeled precursor is a prerequisite to follow brain metabolism. 
13
C-
labeled metabolites are infused in the blood circulation of the animal, at a rather high 
concentration, which leads to hyperglycemia with the main 
13
C-labeled precursor used, i.e. 
13
C-
glucose, a point that is often neglected but has an impact when studying brain metabolism. 
Moreover, this labeled substrate, infused in the blood circulation, is not only metabolized by the 
brain but also by other organs, such as the liver for example, which may scramble the position of 
the 
13
C in some metabolites that go back to the blood and then to the brain, and thus complicates 
the analyses at the cerebral level. However, 
13
C-MRS is a powerful technique since the fate of the 
13
C can be followed and the exact labeled carbon positions of each detected metabolite can be 
determined and quantified, allowing the pathway taken by the 
13
C-labeled precursor to be traced 
back (Rodrigues et al., 2013; Rothman et al., 1999). Even if this technique does not reach cellular 
resolution, it can distinguish between a predominant neuronal or astrocytic metabolism. This is 
based on the principle that neurons and astrocytes differentially express some enzymes; e.g. 
glutamine synthase and pyruvate carboxylase. 
Several approaches have been developed to overcome the low sensitivity of MRS. First, since the 
signal is directly proportional to the field strength, companies develop magnets with increasing 
magnetic fields. Secondly, the 
13
C weak signal can be detected by 
1
H-MRS using proton-observed 
carbon-edited (POCE) sequences. Finally, improved sensitivity for 
13
C can be attained with 
polarization transfer experiments, which partly transfer energy from electron to nucleus, 
increasing the signal by 10,000 times, but only for some tens of seconds. Even if MRS is not a very 
sensitive technique, this relative weakness is also its strength, enabling NMR to study living 
organisms without significantly disturbing them and thus yielding detailed metabolic information 
non-invasively, which allows longitudinal studies (Stagg and Rothman, 2014; de Graaf, 2013). 
In parallel to in vivo MRS, ex vivo NMR spectroscopy is also often used to explore details of brain 
metabolism (Fig. 3D). One of the biggest advantages of ex vivo NMR spectroscopy is achieving very 
high-resolution spectra and metabolic profiles. Spectra can be obtained either on perchloric acid 
extracts of cell cultures or tissues. Alternatively, with the use of special NMR probes such as 
HRMAS (high resolution magic angle spinning) it is now possible to achieve the same high spectral 
resolution on biopsies (without any biochemical treatment) as at obtained in liquid state NMR 
(extracts). The very recent development of the micro HRMAS probe (HRµMAS) allows for high 
quality spectra on nanoliter-sized samples (Duong et al., 2016). An important issue when 
performing ex vivo analyses is to completely stop metabolism before acquiring the spectra. For cell 
cultures, the cellular layer is quickly rinsed with cold PBS (to avoid any contamination with 
medium metabolites) and cells are further either frozen with liquid nitrogen or directly extracted 
with perchloric acid. For brain biopsies, the only technique to avoid any post-mortem metabolism 
is to use focused microwaves. In less than one second, brain temperature reaches 70-80 °C, a 
temperature at which proteins are denatured and thus all enzymatic activities stop. The brain can 
be then taken out of the skull and a precise brain region can be either directly analyzed by HRMAS 
NMR spectroscopy or further processed with perchloric acid extraction of the metabolites for later 
liquid state NMR analyses.  
The technical considerations described above are valid for all observed nuclei (
1
H, 
13
C, 
31
P, etc). For 
13
C, the use of 
13
C-labeled precursors is also needed (see in vivo spectroscopy paragraph). 
However, natural abundance can also be observed with ex vivo NMR spectroscopic studies, 
compared to in vivo studies, since long time acquisition (several hours) can be performed. Finally, 
the high spectral resolution of ex vivo NMR spectroscopy permits analysis of what is called 
homonuclear spin coupling. When several 
13
C are located on the same molecule, the resonance of 
the observed carbon is split and multiplets will appear. The analysis of these homonuclear spin-
coupling patterns represents a unique advantage over other metabolic monitoring techniques 
such as radioactivity (Rodrigues et al., 2013). 
 
C.7 Metabolomics, mass spectrometry and stable isotope tracing 
Metabolomics. Cataloguing the complement of metabolites in a biological sample can lend 
important insight, particularly in the search for disease biomarkers. Mass spectrometry and proton 
NMR are generally the methods of choice for metabolomics (Dumas and Davidovic, 2015). Proton 
NMR, a faster technique that can have a simpler sample preparation than mass spectrometry, 
measures metabolites in the low micromolar range, and has been used extensively in the 
characterization of CNS disorders (see Section C.6 and Oz et al., 2014), whereas mass 
spectrometry can detect picomolar and even femtomolar quantities of metabolites with time-of-
flight and quadrupole time-of-flight detection systems.  However, mass spectrometry typically 
involves a more complex sample extraction, derivatization of the metabolites to facilitate 
detection, and separation techniques prior to injection of a sample into the mass spectrometer.  In 
general, methanol:chloroform extraction allows separation of polar and non-polar metabolites, 
and gas chromatography is used to further separate polar compounds, whereas liquid 
chromatography is used to separate non-polar metabolites. Following separation, the samples are 
ionized, and are separated and/or further fragmented in the mass spectrometer that detects the 
species based upon their mass/charge (m/z) ratio.  Each metabolite generates its own pattern of 
peaks in the m/z spectrum, and the peak heights generally correlate with metabolite 
concentration.  Huge quantities of data are generated by mass spectrometry, thus sophisticated 
systems biology data analysis tools are used to interpret the spectra, to detect differences 
between samples, and to define changes in patterns of related metabolites and metabolic 
pathways.  Such approaches have been used to identify changes in the metabolome in a wide 
variety of neurodegenerative diseases in humans and in animal models (Dumas and Davidovic, 
2015). 
A particular challenge with metabolomics is to determine the meaning and significance of the 
multitude of findings with respect to cell and tissue health or to disease etiology. Relatively low 
throughput and intensive data analysis, as well as the high cost of state-of-the art LC- and GC-mass 
spectrometers present additional challenges. In metabolomics, spatial and subcompartmental 
information is lost except for the regional information provided by NMR-based spectroscopy.  
However, mass spectroscopy imaging is beginning to address cellular, and even subcellular 
resolution of metabolites using fluorinated nanoparticles in nanostructure-initiator mass 
spectroscopy and related approaches (Kurczy et al., 2015). If a metabolite concentration increases, 
it is unclear whether the change arises from enhanced production, or decreased consumption of 
the intermediate, as metabolomics is generally based on data gathered from a single snapshot-in-
time. Thus, whether or not there are alterations in the flux of a metabolite through a metabolic 
pathway cannot readily be discerned.  Computational flux balance can yield estimates of metabolic 
flux without labeling, but the approach is entirely reliant on existing knowledge of enzyme kinetics 
and pathways and thus has limitations (Aurich and Thiele, 2016). 
Stable isotope tracing. By labeling and following carbon through metabolic pathways, stable 
isotope tracing can address questions regarding the extent and pattern of flux through metabolic 
pathways (Buescher et al., 2015). Stable isotope tracers are non-radioactive and naturally 
occurring, and are therefore safe. The technique is typically destructive to the sample to enable 
mass spectrometry, but can be performed on cultured cells, tissues, and in vivo.  NMR can instead 
be used for detection, with a significant sacrifice in sensitivity (Rodrigues et al., 2013). 
13
C-
containing molecules like glucose and glutamine have been used extensively, as the 
13
C in the 
parent molecule is transferred to downstream metabolites that can be detected by mass 
spectrometry (Fig. 3D). The extent to which metabolites become enriched with 
13
C combined with 
an analysis of the concentration of the metabolite is an indication of the flux through the 
metabolic pathway. The same, in principle, is true for 
15
N- and 
3
H-labeled substrates.
  
For isotope 
tracing with cells in culture, a full complement of growth media is typically added with 
replacement of a fuel like glucose with 
13
C-labeled glucose. The system is incubated for a sufficient 
time to allow the sample to come to isotopic steady state, and then the media is removed and the 
sample is extracted and derivatized for analysis by mass spectrometry.   The spectral peaks for 
each metabolite are then used to quantify its abundance as well as the mass isotopomer 
distribution (the fraction of a metabolite enriched with zero, 1, 2, 3, etc 
13
C-labeled carbons).  
From these data, as well as separate experiments using other metabolic tracers, the extent of 
carbon flux from different substrates into the pool of a particular metabolite and its precursors 
can be calculated (Kelleher and Nickol, 2015). The ability to resolve cell-type specific metabolism in 
brain tissue or co-cultures is somewhat limited, and is reliant on either pharmacologic agents or 
genetic manipulation of isoforms of metabolite transporters or enzymes to control metabolism in 
particular cell types. Stable isotope tracing can determine the relative rates of flux of one labeled 
substrate versus another. Quantitative rates of flux can be determined by an extension of the 
technique termed metabolic flux analysis whereby the 
13
C-labeling pattern of intracellular 
metabolites is pinned to the rates of uptake and release of metabolites from a biological system.  
The data is applied to a computational network model of biochemical reactions that enables 
quantitative estimates of flux through specific pathways (Buescher et al., 2015). The approach is 
more labor- and data-intensive than stable isotope tracing, and is reliant on a robust 
computational model that accounts for all potential reaction pathways. 
Finally, in a particularly powerful approach, stable isotope tracing with mass spectrometry can be 
coupled with real-time measurements of metabolic flux using respirometry (a technique described 
in detail in Section C.1). The depth of insight provided by the combination of the two approaches is 
greater than either technique alone, and has been applied to the study of cultured cortical 
neurons (Divakaruni et al., 2017), the mouse retina (Du et al., 2016), and glioma metabolism and 
growth (Yang et al., 2014a). 
 
C.8 Mathematical modeling 
Mathematical modeling aims to integrate the outcome of multiple experimental techniques in 
order to grasp complex behaviors that are otherwise impenetrable. It serves to identify variables 
and parameters that are critical and should therefore be given experimental attention, to then 
guide the design of experiments by a priori, inexpensive visualization of possible outcomes. At its 
best, it may prefigure novel phenomena. In the specific case of brain energy metabolism, models 
combine structural parameters of brain tissue with the microscopic properties of enzymes and 
transporters in view of dynamic readouts obtained by technologies like PET, MRS, fMRI, tissue 
electrodes, microdialysis, and genetically-encoded nanosensors. A key well-substantiated 
assumption of current models is that metabolism is compartmentalized, that is, that it occurs in a 
few well-mixed reservoirs (say neuronal and glial). Thus, chemical and transport reactions can be 
represented by a small set of ordinary differential equations that are solved by numerical 
simulation using standard computers. The outcome of a model is as good as what the model is fed, 
and so different groups have arrived at opposite conclusions: witness the astrocyte-to-neuron 
lactate shuttle controversy (Hyder et al., 2006; Aubert and Costalat, 2007; Mangia et al., 2009; 
Jolivet et al., 2015). While debate speaks of a lively discipline, assumptions about key parameters 
are often hidden, and so it has been hard for the non-initiated to judge the relative merits of 
competing models (Jolivet et al., 2010). In view of structural, functional, and likely metabolic 
heterogeneity of neurons and glial cells (DeFelipe et al., 2013; Freeman, 2015), future models will 
have to become more complex, as has recently occurred for neuronal ATP subcellular domains (Le 
Masson et al., 2014). The next generation of models will also have to deal with growing evidence 
for fast local regulation of enzymes, transporters and channels in response to neural activity 
(Barros et al., 2013). However, it is important to understand that a more complex model (i.e. 
which include more equations and more parameters) is not necessarily better to adequately 
describe the different possible outcomes of a system. It all depends on the question(s) that 
need(s) to be addressed.  
  
 BOX 1      The BOLD-fMRI method: relationship with energy metabolism  
 
MRI is well known for its capacity to non-invasively provide high resolution images of brain 
structures. MRI can also be rendered sensitive to local magnetic field inhomogeneity. This 
principle has been applied to develop the most common modality of fMRI, where the so-called 
Blood Oxygenation Level Dependent (BOLD) effect on magnetic field inhomogeneity is detected 
during brain activity. The BOLD effect relies on the local transient increase of the oxyhemoglobin-
to-deoxyhemoglobin ratio during the haemodynamic response associated with neuronal activity 
(Ogawa et al., 1990). Since deoxyhemoglobin induces magnetic inhomogeneity, activated regions 
of the brain, with less deoxyhemoglobin, exhibit a stronger BOLD signal. BOLD-fMRI is either used 
with task-based paradigms, in which the mean of the baseline state is subtracted from the mean 
of the stimulated state to identify activated regions associated with the task, or it is used to study 
the brain at rest, in the absence of an explicit task (resting state BOLD-fMRI; Gusnard et al., 2001). 
BOLD contrast fMRI has come to dominate the functional neuroimaging field. 
The BOLD-fMRI signal is not a straightforward measure of energy metabolism. The 
deoxyhemoglobin content within a voxel is determined by the balance between the supply of 
oxygenated blood, the rate of oxygen consumption and the fractional blood volume. This is 
because the supply of oxygen is not matched precisely with the demand that the BOLD-fMRI 
signals change in regions where the actual amount of oxygen remaining in blood vessels is 
modified during activation. Hence, the BOLD response is dependent upon hemodynamic (blood 
flow and volume) and metabolic (oxygen consumption) responses. Although the value of BOLD 
fMRI for functional brain mapping is undisputed, the more subtle questions of how to interpret 
and use BOLD response magnitude and changes to derive information about energy metabolism 
are still unresolved. A reduction in the BOLD signal can result from a reduced neuronal activation, 
abnormal neuron/astrocyte coupling, a reduced vascular response, or a combination of all these 
components of the neurovascular response. 
Quantitative fMRI techniques have been developed to measure the hemodynamic and metabolic 
responses to modulations in brain activity (Pike, 2012). They include arterial spin labeling (ASL) to 
measure variations in tissue perfusion in each pixel (which can help to disentangle confounding 
mechanisms), contrast agents to measure cerebral blood volume (CBV) and calibrated fMRI using 
biophysical models of the BOLD signal to estimate changes in the cerebral metabolic rate of 
oxygen consumption (CMRO2). Calibrated fMRI may be used as a biomarker of brain disorders 
that could be applied for therapy monitoring. 
 
Concluding Remarks 
The diversity, range and depth of the techniques applied to the study of brain energy metabolism 
are amazing, as is the complexity of the problem in hand. As we are now gaining access to the 
particular metabolic behavior of specific brain areas, cell types and even individual cells, 
techniques are becoming more and more sophisticated, each own having its own domain, 
strengths and limitations (Table 1). A challenge for the near future is to increase the crosstalk 
between technical viewpoints, perhaps through the active exchange of ideas and collaboration 
between dedicated laboratories.    
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Figure legends 
 
Figure 1. Hierarchical organization of brain energy metabolism. Structural levels result from  
binding forces becoming weaker as small structures accrete into larger ones but also have an 
evolutionary explanation (Simon, 1962). The hierarchical organization of brain metabolism 
explains the success of reductionist investigative approaches. 
Figure 2 Technical domains in brain energy metabolism research. Different techniques perform 
over different domains, which are in turn defined by a combination of organizational level, 
experimental control and relevance to human physiology. For example, electrophysiology achieves 
excellent experimental control at small and intermediate hierarchies by in vitro recording from 
single channels, single cells or small cell assemblies, but it is not practical in vivo and cannot be 
used in humans. MRS, in contrast, may be applied to human subjects, but has limited experimental 
control and provides time- and space-averaged measurements. 
Figure 3. Examples of recent data in brain energy metabolism. A. Astrocytes in organotypic 
hippocampal slice culture were transfected with cDNA constructs encoding for hexokinase-ECFP 
and GLT1-mCherry using a gene-gun. B. In vivo [
14
C]-2-deoxyglucose uptake, obtained as described 
in Boussicault et al., 2014. C. 
1
H-MRS data obtained in a rat, at rest or during whisker stimulation. 
The difference between the two conditions reveals an increase in tissue lactate. The BOLD fMRI 
response was elicited with the same paradigm. D. Rat neurons in culture were exposed to 3-
13
C1 
glucose so that the labeled carbon is lost via the PDH reaction but retained by the anaplerotic 
reactions of pyruvate carboxylase (PC) and malic enzyme (ME), from Divakaruni et al., 2017. E. 
Perturbation of hippocampal fuel fluxes during a memory task (adapted from Newman et al., 
2011). F. Lactate-mediated depolarization and firing of a neuron in the locus coeruleus after 
optogenetic stimulation of neighboring astrocytes (adapted from Tang et al., 2014). G. The graph 
show the biphasic response to astrocytic lactate levels as detected with Laconic during local 
stimulation of the somatosensory cortex (from Sotelo-Hitschfeld et al., 2015). The top image 
shows the expression of Laconic and Pyronic in neurons and astrocytes of the somatosensory 
cortex using viral vectors (adapted from Machler et al., 2016). Bottom images were taken from a 
transgenic mouse expressing ATeam in neurons described in Trevisiol et al., 2017.  
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